Rachel Wilson - R1 RCM CFO VP
| RCMDelisted Stock | USD 14.31 0.01 0.07% |
Insider
Rachel Wilson is CFO VP of R1 RCM Inc
| Age | 51 |
| Phone | 312-324-7820 |
| Web | https://www.r1rcm.com |
R1 RCM Management Efficiency
The company has Return on Asset of 0.0235 % which means that on every $100 spent on assets, it made $0.0235 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.022) %, meaning that it generated no profit with money invested by stockholders. R1 RCM's management efficiency ratios could be used to measure how well R1 RCM manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Max Wygod | Forian Inc | 36 | |
| Jim MD | Privia Health Group | N/A | |
| Teresa McMeans | CareMax | N/A | |
| David Kronfeld | Definitive Healthcare Corp | N/A | |
| Jona Raasch | National Research Corp | 65 | |
| Dave Ross | Health Catalyst | N/A | |
| , PharmD | Certara | N/A | |
| Michael Vesey | Forian Inc | 62 | |
| Richard Booth | Definitive Healthcare Corp | 55 | |
| Nicole Cable | CareMax | N/A | |
| Carlos Solo | CareMax | 45 | |
| Joseph Mirisola | Definitive Healthcare Corp | 40 | |
| Jason Alger | Health Catalyst | 40 | |
| Jaap Mandema | Certara | N/A | |
| Aammaad Shams | Evolent Health | 40 | |
| William Feehery | Certara | 53 | |
| Kali Beyah | Evolent Health | N/A | |
| Kate Jensen | Definitive Healthcare Corp | 38 | |
| William Frederick | Simulations Plus | 60 | |
| M Duffy | Evolent Health | 61 | |
| Paul Horstmeier | Health Catalyst | 63 | |
Management Performance
| Return On Equity | -0.022 | ||||
| Return On Asset | 0.0235 |
R1 RCM Inc Leadership Team
Elected by the shareholders, the R1 RCM's board of directors comprises two types of representatives: R1 RCM inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RCM. The board's role is to monitor R1 RCM's management team and ensure that shareholders' interests are well served. R1 RCM's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, R1 RCM's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sean Radcliffe, General VP | ||
| Pamela Spikner, Principal Officer | ||
| Atif Rahim, Sr Devel | ||
| Brian Gambs, EVP Officer | ||
| Joseph Flanagan, President CEO, Director | ||
| Kate Sanderson, Executive Officer | ||
| Evan CFA, Senior Relations | ||
| David Strickle, Executive Integration | ||
| Jennifer Williams, CFO VP | ||
| Gary Long, Executive Vice President Chief Commercial Officer | ||
| Jay Sreedharan, Chief Officer | ||
| Lee Rivas, CEO Director | ||
| Richard Evans, Corporate VP | ||
| Sean JD, General VP | ||
| Kyle Hicok, Executive Officer | ||
| Logan Johnston, Executive Management | ||
| Rachel Wilson, CFO VP | ||
| John Sparby, President | ||
| Corey Perman, Executive Risk |
RCM Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is R1 RCM a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.022 | ||||
| Return On Asset | 0.0235 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 8.19 B | ||||
| Shares Outstanding | 422.39 M | ||||
| Shares Owned By Insiders | 1.04 % | ||||
| Shares Owned By Institutions | 86.91 % | ||||
| Number Of Shares Shorted | 10.81 M | ||||
| Price To Earning | 75.00 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in R1 RCM Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in RCM Stock
If you are still planning to invest in R1 RCM Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the R1 RCM's history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |